Jennifer Couzin. Show Affiliations »
Abstract
Mesh: See more » Advisory CommitteesAnti-Inflammatory Agents, Non-Steroidal/adverse effectsAnti-Inflammatory Agents, Non-Steroidal/therapeutic useCardiovascular Diseases/chemically inducedCardiovascular Diseases/epidemiologyCelecoxibCyclooxygenase Inhibitors/adverse effectsCyclooxygenase Inhibitors/therapeutic useDrug LabelingDrug and Narcotic ControlHumansIsoxazoles/adverse effectsIsoxazoles/therapeutic useLactones/adverse effectsLactones/therapeutic usePyrazoles/adverse effectsPyrazoles/therapeutic useStroke/chemically inducedStroke/epidemiologySulfonamides/adverse effectsSulfonamides/therapeutic useSulfones/adverse effectsSulfones/therapeutic useUnited StatesUnited States Food and Drug Administration
Substances: See more » Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsIsoxazolesLactonesPyrazolesSulfonamidesSulfonesrofecoxibvaldecoxibCelecoxib
Year: 2005 PMID: 15731414 DOI: 10.1126/science.307.5713.1183a
Source DB: PubMed Journal: Science ISSN: 0036-8075 Impact factor: 47.728